Developer docs
API playgroundTry for free, no card

Search company profiles

Aware

Full company profile

uuid0000cwr

Namestring
Aware
Legal namestring
Aware Health GmbH
Websiteurl
aware.app
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Aware Health GmbH is a Berlin-based, privately held health technology company that operates a direct-to-consumer blood testing service marketed primarily to health-conscious consumers in Germany, Austria, and the Netherlands. Its core offering comprises five fixed-price blood test packages — Holistic Health (from €149, up to 78 markers), Nutrition (from €139, up to 29 markers), Hormones (from €189, 9 markers), Sports (from €79, up to 54 markers), and Body Weight (from €125, up to 68 markers) — covering in aggregate more than 90 biomarkers across immunity, heart health, hormones, metabolism, micronutrients, and inflammation. Customers book 15-minute appointments at more than 45 partner lab collection points across 30+ German cities plus Vienna and Amsterdam, with results analyzed in accredited German labs and delivered through a dedicated iOS/Android app within roughly 48 hours, where they can view explanations, trend lines, and recommended actions.

Underlying the consumer brand is a biomarker data platform whose longitudinal goal — articulated at the time of the seed round — is to build a large anonymized health database to underpin personalized medicine offerings. The mobile app functions as the engagement surface for tracking biomarkers over time, while the lab and logistics network, including a retail partnership with dm drogeriemarkt in Berlin and Karlsruhe, functions as the physical fulfillment layer. Tests are processed in certified German labs under RiliBAK standards, and the company operates within full GDPR data-protection compliance.

Aware's commercial model combines one-time test purchases (€79–€189) with an annual subscription product, AwarePro, priced at €129 per year, which provides access to up to 78 biomarkers, 20+ personalized retesting panels, and a 20% discount on follow-up tests. Demand is generated through app store presence, an in-house "Aware Magazine," symptom-based quiz funnels, and email newsletters. The company is venture-backed, having closed a $15 million seed round in June 2022 co-led by Cherry Ventures and Lakestar, with participation from Amino Collective, Atlantic, June Fund, and Magnetic Capital. Headcount sits in the 11–50 band, the company is operationally active, and there are no public listing, M&A, or parent-company signals in the available data.

Short descriptiontext

Aware Health GmbH operates a direct-to-consumer blood testing service in the DACH region and the Netherlands, offering five fixed-price packages covering 90+ biomarkers through 45+ partner lab locations, with results delivered via a dedicated mobile app and a €129/year AwarePro subscription.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices36 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blood testing services, biomarker analysis, preventive health diagnostics, mobile health tracking, direct-to-consumer lab testing
Industry2 codes
1Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryYes
2Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Direct-to-Consumer Preventive Blood Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1One-time Blood Test Packages
TypeOne Time License
Description

Individual test packages sold at fixed prices ranging from €79 to €189 depending on panel complexity (Sports, Holistic Health, Nutrition, Hormones, Body Weight)

aware.app
2AwarePro Subscription
TypeSubscription Recurring
Description

Annual membership at €129/year providing access to up to 78 biomarkers, 20+ panels for personalized retesting, ongoing 20% savings on follow-up tests, and comprehensive trend tracking in app

aware.app
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain
Pricing details6 tiers
1AwarePro Annual Membership
ModelSubscriptionBilling cadenceAnnual
Notes

€129/year. Access to up to 78 biomarkers, 20+ panels for personalized retesting, 20% savings on follow-up tests, clear trend visualization in app, flexible cancellation before renewal

aware.app
2Holistic Health Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at €149. Entry-level data-driven supplementation package. Up to 78 health markers including Blood Count, Micronutrients, Liver & Kidney Function, Inflammation. Results in 2-10 working days

aware.app
3Nutrition Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at €139. Up to 29 health markers covering Blood Count, Micronutrients, Iron status, Homocysteine. Results in 2-10 working days

aware.app
4Hormones Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at €189. 9 health markers covering Thyroid, Sex hormones, SHBG, Prolactin, Cortisol. Results in 10 working days

aware.app
5Sports Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at €79. Up to 54 health markers covering Muscle metabolism, Inflammation, Micronutrients, Energy metabolism, Blood count

aware.app
6Body Weight Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at €125. Up to 68 biomarkers covering Blood lipids, Glucose & insulin metabolism, Hormones, Inflammation, Liver & kidney, Micronutrients. Analysis of metabolism, energy balance and weight regulation. Results in 2-10 business days

aware.app
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Aware sells direct-to-consumer holistic blood test packages that analyze 90+ biomarkers (covering immunity, heart health, blood count, hormones, metabolism, minerals, vitamins, and liver/kidney function). Customers book a 15-minute blood draw at one of 45+ partner labs across Germany, Austria, and the Netherlands, and receive results in the Aware mobile app within 48 hours, with explanations, personalized action plans, and longitudinal trend tracking.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90+ biomarkers analyzed in single test
+3 more records
Product overview1 text field

Aware is a German health technology company offering holistic blood testing services with over 90 biomarkers analyzed. The core offering consists of five distinct health test packages: Holistic Health (up to 78 markers), Nutrition (up to 29 markers), Hormones (9 markers), Sports (up to 54 markers), and Body Weight (up to 68 markers). These tests are conducted at partner laboratory locations across Germany and Vienna, with results delivered via a mobile app. The company also offers an AwarePro annual subscription providing ongoing access to biomarker monitoring and personalized retesting panels. Tests are analyzed in certified German labs meeting RiliBAK quality standards with full GDPR data protection compliance.

Product and service7 records
1Aware Holistic Health
CategoryHealth test package
Description

Entry-level holistic blood test package analyzing up to 78 health markers including Blood Count, Micronutrients, Liver & Kidney Function, and Inflammation; intended for individual consumers seeking a broad preventive-health baseline; results delivered in 2–10 working days; priced from €149.

2Aware Nutrition
CategoryHealth test package
Description

Nutrition-focused blood test analyzing up to 29 health markers covering Blood Count, Micronutrients, Iron status, and Homocysteine; intended for individual consumers evaluating diet-driven nutrient status; results delivered in 2–10 working days; priced from €139.

3Aware Hormones
CategoryHealth test package
Description

Hormone panel measuring 9 health markers including Thyroid, Sex hormones, SHBG, Prolactin, and Cortisol; intended for individual consumers investigating hormonal balance, fertility, fatigue, or stress-related symptoms; results delivered in 10 working days; priced from €189.

4Aware Sports
CategoryHealth test package
Description

Sports and fitness blood test analyzing up to 54 health markers covering Muscle metabolism, Inflammation, Micronutrients, Energy metabolism, and Blood count; intended for individual consumers focused on athletic performance, recovery, and training optimization; results delivered in 2–10 working days; priced from €79.

5Aware Body Weight
CategoryHealth test package
Description

Weight management blood test analyzing up to 68 biomarkers covering Blood lipids, Glucose & insulin metabolism, Hormones, Inflammation, Liver & kidney, and Micronutrients, focusing on metabolism, energy balance, and weight regulation; intended for individual consumers managing weight or metabolic health; results delivered in 2–10 business days; priced from €125.

6AwarePro Membership
CategorySubscription service
Description

Annual subscription membership granting access to up to 78 biomarkers and 20+ panels for personalized retesting, 20% savings on follow-up tests, longitudinal trend visualization in the app, and flexible cancellation before renewal; intended for individual consumers committed to ongoing health monitoring; priced at €129/year.

7Aware Mobile App
CategoryMobile application
Description

iOS and Android mobile application enabling users to book lab appointments, view biomarker results with plain-language explanations, track biomarker trends over time, receive personalized retest recommendations, and access action plans; intended for individual consumers using Aware's blood testing services.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Retail partnership with dm drogeriemarkt for physical lab locations. Two locations operational: Berlin (Tauentzienstraße 2-3) and Karlsruhe (Kaiserstraße 146). Provides physical retail presence and walk-in appointment availability with extended hours including evenings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hamburg-based DTC blood and saliva testing company offering 50+ biomarker panels with mobile app delivery. Direct head-to-head competitor in German DTC diagnostics with overlapping product positioning and customer segments.

TypeDirect peer
Description

Berlin-based DTC blood-testing startup analyzing 150+ biomarkers with mobile tracking. Operates in the same DACH consumer biomarker-testing category with a similar subscription/one-time pricing structure and app-centric experience.

TypeDirect peer
Description

London-based DTC blood-testing company with finger-prick at-home kits and subscription plans. Closest UK analog to Aware's model — biomarker panels, recurring memberships, and trend-tracking app — useful for benchmarking European DTC unit economics.

TypeDirect peer
Description

UK/US personalized nutrition platform that combines blood biomarker testing with gut microbiome and continuous glucose monitoring. Represents the upper-bound of the DTC preventive health category Aware is moving toward.

TypeDirect peer
Description

US-based personalized health platform offering blood biomarker analysis with food/supplement recommendations and trend tracking. Closest US analog to Aware's holistic biomarker-plus-recommendation model.

TypeEmerging player
Description

US-based gut microbiome and blood-based RNA testing platform with personalized nutrition recommendations. Adjacent in the consumer preventive-health category, with partial overlap in the blood biomarker + diet/supplementation positioning.

TypeEmerging player
Description

Microbiome-based personalized nutrition platform that also uses blood biomarkers. Comparable as a 'test + personalized intervention' consumer health play, with a more clinical/enterprise orientation.

TypeEmerging player
Description

US-based at-home blood-testing-as-a-service company providing nutrient testing with subscription supplements. Mirrors Aware's 'test-then-supplement' value chain, useful for assessing D2C supplement attachment economics.

TypeRegional player
Description

Austria-based gut microbiome testing company selling direct to consumers across DACH. Comparable as a regional European personalized health-testing brand operating with the same customer persona.

TypeBroad incumbent
Description

Large life-sciences incumbent investing in preventive metabolic health. Represents the broad-incumbent threat — large balance sheets, regulatory expertise, and potential to bundle biomarker testing with consumer-facing cardiometabolic products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aware

Direct-to-Consumer Preventive Blood Diagnosticsaware.app

Aware Health GmbH operates a direct-to-consumer blood testing service in the DACH region and the Netherlands, offering five fixed-price packages covering 90+ biomarkers through 45+ partner lab locations, with results delivered via a dedicated mobile app and a €129/year AwarePro subscription.

What Aware does

Aware Health GmbH is a Berlin-based, privately held health technology company that operates a direct-to-consumer blood testing service marketed primarily to health-conscious consumers in Germany, Austria, and the Netherlands. Its core offering comprises five fixed-price blood test packages — Holistic Health (from €149, up to 78 markers), Nutrition (from €139, up to 29 markers), Hormones (from €189, 9 markers), Sports (from €79, up to 54 markers), and Body Weight (from €125, up to 68 markers) — covering in aggregate more than 90 biomarkers across immunity, heart health, hormones, metabolism, micronutrients, and inflammation. Customers book 15-minute appointments at more than 45 partner lab collection points across 30+ German cities plus Vienna and Amsterdam, with results analyzed in accredited German labs and delivered through a dedicated iOS/Android app within roughly 48 hours, where they can view explanations, trend lines, and recommended actions.

Underlying the consumer brand is a biomarker data platform whose longitudinal goal — articulated at the time of the seed round — is to build a large anonymized health database to underpin personalized medicine offerings. The mobile app functions as the engagement surface for tracking biomarkers over time, while the lab and logistics network, including a retail partnership with dm drogeriemarkt in Berlin and Karlsruhe, functions as the physical fulfillment layer. Tests are processed in certified German labs under RiliBAK standards, and the company operates within full GDPR data-protection compliance.

Aware's commercial model combines one-time test purchases (€79–€189) with an annual subscription product, AwarePro, priced at €129 per year, which provides access to up to 78 biomarkers, 20+ personalized retesting panels, and a 20% discount on follow-up tests. Demand is generated through app store presence, an in-house "Aware Magazine," symptom-based quiz funnels, and email newsletters. The company is venture-backed, having closed a $15 million seed round in June 2022 co-led by Cherry Ventures and Lakestar, with participation from Amino Collective, Atlantic, June Fund, and Magnetic Capital. Headcount sits in the 11–50 band, the company is operationally active, and there are no public listing, M&A, or parent-company signals in the available data.

Aware firmographics

Firmographics
Name
Aware
Legal name
Aware Health GmbH
Website
https://aware.app
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Aware Health GmbH operates a direct-to-consumer blood testing service in the DACH region and the Netherlands, offering five fixed-price packages covering 90+ biomarkers through 45+ partner lab locations, with results delivered via a dedicated mobile app and a €129/year AwarePro subscription.
Ownership category
akta.pro rank

Aware industry classification

Industry
Product category
Direct-to-Consumer Preventive Blood Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
akta.pro secondary industry
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

  • Blood testing services
  • Biomarker analysis
  • Preventive health diagnostics
  • Mobile health tracking
  • Direct-to-consumer lab testing

Where Aware is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices36 records

Markets served

Aware business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. One-time Blood Test Packages: Individual test packages sold at fixed prices ranging from €79 to €189 depending on panel complexity (Sports, Holistic Health, Nutrition, Hormones, Body Weight)
  2. AwarePro Subscription: Annual membership at €129/year providing access to up to 78 biomarkers, 20+ panels for personalized retesting, ongoing 20% savings on follow-up tests, and comprehensive trend tracking in app

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAwarePro Annual Membership
Unit PricingPay-as-you-goHolistic Health Package
Unit PricingPay-as-you-goNutrition Package
Unit PricingPay-as-you-goHormones Package
Unit PricingPay-as-you-goSports Package
Unit PricingPay-as-you-goBody Weight Package

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Aware product offering

Product offering

Core offering

Aware sells direct-to-consumer holistic blood test packages that analyze 90+ biomarkers (covering immunity, heart health, blood count, hormones, metabolism, minerals, vitamins, and liver/kidney function). Customers book a 15-minute blood draw at one of 45+ partner labs across Germany, Austria, and the Netherlands, and receive results in the Aware mobile app within 48 hours, with explanations, personalized action plans, and longitudinal trend tracking.

Product overview

Aware is a German health technology company offering holistic blood testing services with over 90 biomarkers analyzed. The core offering consists of five distinct health test packages: Holistic Health (up to 78 markers), Nutrition (up to 29 markers), Hormones (9 markers), Sports (up to 54 markers), and Body Weight (up to 68 markers). These tests are conducted at partner laboratory locations across Germany and Vienna, with results delivered via a mobile app. The company also offers an AwarePro annual subscription providing ongoing access to biomarker monitoring and personalized retesting panels. Tests are analyzed in certified German labs meeting RiliBAK quality standards with full GDPR data protection compliance.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aware Holistic Health Entry-level holistic blood test package analyzing up to 78 health markers including Blood Count, Micronutrients, Liver & Kidney Function, and Inflammation; intended for individual consumers seeking a broad preventive-health baseline; results delivered in 2–10 working days; priced from €149.
  • Aware Nutrition Nutrition-focused blood test analyzing up to 29 health markers covering Blood Count, Micronutrients, Iron status, and Homocysteine; intended for individual consumers evaluating diet-driven nutrient status; results delivered in 2–10 working days; priced from €139.
  • Aware Hormones Hormone panel measuring 9 health markers including Thyroid, Sex hormones, SHBG, Prolactin, and Cortisol; intended for individual consumers investigating hormonal balance, fertility, fatigue, or stress-related symptoms; results delivered in 10 working days; priced from €189.
  • Aware Sports Sports and fitness blood test analyzing up to 54 health markers covering Muscle metabolism, Inflammation, Micronutrients, Energy metabolism, and Blood count; intended for individual consumers focused on athletic performance, recovery, and training optimization; results delivered in 2–10 working days; priced from €79.
  • Aware Body Weight Weight management blood test analyzing up to 68 biomarkers covering Blood lipids, Glucose & insulin metabolism, Hormones, Inflammation, Liver & kidney, and Micronutrients, focusing on metabolism, energy balance, and weight regulation; intended for individual consumers managing weight or metabolic health; results delivered in 2–10 business days; priced from €125.
  • AwarePro Membership Annual subscription membership granting access to up to 78 biomarkers and 20+ panels for personalized retesting, 20% savings on follow-up tests, longitudinal trend visualization in the app, and flexible cancellation before renewal; intended for individual consumers committed to ongoing health monitoring; priced at €129/year.
  • Aware Mobile App iOS and Android mobile application enabling users to book lab appointments, view biomarker results with plain-language explanations, track biomarker trends over time, receive personalized retest recommendations, and access action plans; intended for individual consumers using Aware's blood testing services.

Quantifiable outcome

  • 90+ biomarkers analyzed in single test
  • +3 more outcomes

Companies that use Aware

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Aware technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Aware partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • dm drogeriemarktcoreChannel Partner/ Reseller/ DistributorRetail partnership with dm drogeriemarkt for physical lab locations. Two locations operational: Berlin (Tauentzienstraße 2-3) and Karlsruhe (Kaiserstraße 146). Provides physical retail presence and walk-in appointment availability with extended hours including evenings.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Aware competitors and assessment

Company assessment

Direct peers

  • Cerascreen: Hamburg-based DTC blood and saliva testing company offering 50+ biomarker panels with mobile app delivery. Direct head-to-head competitor in German DTC diagnostics with overlapping product positioning and customer segments.
  • Lykon: Berlin-based DTC blood-testing startup analyzing 150+ biomarkers with mobile tracking. Operates in the same DACH consumer biomarker-testing category with a similar subscription/one-time pricing structure and app-centric experience.
  • Thriva: London-based DTC blood-testing company with finger-prick at-home kits and subscription plans. Closest UK analog to Aware's model — biomarker panels, recurring memberships, and trend-tracking app — useful for benchmarking European DTC unit economics.
  • Zoe: UK/US personalized nutrition platform that combines blood biomarker testing with gut microbiome and continuous glucose monitoring. Represents the upper-bound of the DTC preventive health category Aware is moving toward.
  • InsideTracker: US-based personalized health platform offering blood biomarker analysis with food/supplement recommendations and trend tracking. Closest US analog to Aware's holistic biomarker-plus-recommendation model.

Emerging players

  • Viome: US-based gut microbiome and blood-based RNA testing platform with personalized nutrition recommendations. Adjacent in the consumer preventive-health category, with partial overlap in the blood biomarker + diet/supplementation positioning.
  • DayTwo: Microbiome-based personalized nutrition platform that also uses blood biomarkers. Comparable as a 'test + personalized intervention' consumer health play, with a more clinical/enterprise orientation.
  • Baze: US-based at-home blood-testing-as-a-service company providing nutrient testing with subscription supplements. Mirrors Aware's 'test-then-supplement' value chain, useful for assessing D2C supplement attachment economics.

Regional players

  • myBioma: Austria-based gut microbiome testing company selling direct to consumers across DACH. Comparable as a regional European personalized health-testing brand operating with the same customer persona.

Broad incumbents

  • novo nordisk (consumer preventive health initiatives): Large life-sciences incumbent investing in preventive metabolic health. Represents the broad-incumbent threat — large balance sheets, regulatory expertise, and potential to bundle biomarker testing with consumer-facing cardiometabolic products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Aware social profiles

Digital presence

Aware compliance and trust

Trust signal

Compliance4 records

Aware financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aware leadership team

Management profile

Number of profiles

Aware funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aware M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aware

What does Aware do?

Aware sells direct-to-consumer holistic blood test packages that analyze 90+ biomarkers (covering immunity, heart health, blood count, hormones, metabolism, minerals, vitamins, and liver/kidney function). Customers book a 15-minute blood draw at one of 45+ partner labs across Germany, Austria, and the Netherlands, and receive results in the Aware mobile app within 48 hours, with explanations, personalized action plans, and longitudinal trend tracking.

Is Aware a public or private company?

Aware is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aware founded?

Aware was founded in 2022. It employs 11 to 50 people.

Where is Aware based?

Aware is headquartered in Berlin, Germany, in the Europe region.

How does Aware make money?

Two revenue lines are on record. One-time Blood Test Packages are the primary driver. The others are awarePro Subscription.

Who are Aware's main competitors?

Direct peers on record are Cerascreen, Lykon, Thriva, Zoe and InsideTracker. Emerging players are Viome, DayTwo and Baze. myBioma is listed as a regional player. novo nordisk (consumer preventive health initiatives) is listed as a broad incumbent.

Does Aware have an API?

No public API is recorded for Aware.

What industry is Aware in?

Aware's product category is Direct-to-Consumer Preventive Blood Diagnostics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireCombat Control Foundation Appoints Sam Kellett Jr. to Board of Directors, Strengthening Strategic LeadershipThe Combat Control Foundation appointed Sam Kellett Jr. to its Board of Directors, bringing his executive experience and fundraising track record. Since 2021, the foundation has delivered over $1.25 million in direct program support to more than 4,700 Air Force Special Warfare operators and their families.Stock TitanAware liveness passes BixeLab tests, zero bypassesAware, Inc. announced the successful completion of an independent Injection Attack Detection evaluation of its Aware Intelligent Liveness solution by BixeLab, a globally recognized biometric testing authority. The testing, conducted in April 2026 in alignment with CEN/TS 18099:2024 technical specification, validated zero successful bypasses across 900 test scenarios including 600 injection attack attempts and 300 legitimate transactions. The results underscore the effectiveness of Aware's biometric security solution against emerging threats and reinforce the company's commitment to third-party validation.openPR.comMarket Driver Insights: The Impact of Recent Advancements on the Decentralized Identity MarketThe decentralized identity market is expected to grow significantly, reaching $48.31 billion by 2030 with a CAGR of 79.8%, driven by technological advances and increasing demand for secure digital identity solutions. Key companies involved include Microsoft Corporation, Accenture plc, and Ping Identity Corporation, with a notable partnership between Aware Inc. and Finema Co. Ltd. in November 2024 to promote biometric digital identity solutions in the Asia-Pacific region.YahooAware, Inc. Q4 2025 Earnings Call SummaryAware, Inc. characterized 2025 as a foundational year focused on a three-pronged transformation of its biometric technology business, with revenue variability attributed to federal market dynamics including delayed appropriations and slower procurement cycles following a government shutdown. The company achieved top-tier results in NIST and DHS evaluations for its "Intelligent Liveness" technology, deployed its first mobile biometric solution within a U.S. federal agency, and expanded internationally through a Caribbean pilot program. Management expects 2026 growth to be driven by converting existing pilot programs and evaluations into production-scale deployments using a "land-and-expand" strategy, with the sales pipeline currently composed of approximately 75% new logos.Biometric UpdateAware holds revenue steady amid shift to biometric identity solutionsAware, a biometric identity solutions provider, reported Q4 revenues of $4.7 million and full-year revenues of $17.3 million, with both figures essentially flat compared to the prior year. The company's net loss widened to $1.5 million in Q4 and $5.9 million for the full year, attributed to increased investments in research and development, personnel, and product development. Aware repositioned itself as a biometric identity solutions provider in 2025 under CEO Ajay Amlani.Investing.comEarnings call transcript: Aware Inc. Q4 2025 results show strategic investments amid flat revenue By Investing.comAware Inc. reported Q4 2025 earnings with revenue of $4.7 million, a 1.9% decline year-over-year, and a widened net loss of $1.5 million compared to $1.2 million in Q4 2024, citing government procurement delays as a key factor. The company's stock dropped 0.61% in aftermarket trading following the earnings release, closing near its 52-week low of $1.37. Management emphasized continued strategic investments in R&D, certifications, and market expansion despite short-term financial pressures, while maintaining a strong balance sheet with $22.3 million in cash and no debt.Biometric UpdateAware passes Level 3 biometric liveness evaluation by BixeLabAware's biometric identity product, Intelligent Liveness, was independently evaluated and certified by BixeLab, an NVLAP-accredited biometric testing laboratory, achieving strong results across all three levels of ISO/IEC 30107-3 Presentation Attack Detection testing, including zero false rejections at Levels 1 and 2 and zero successful attacks at Levels 2 and 3. The company also met all U.S. Department of Homeland Security-defined high performance goals in the 2025 Remote Identity Validation Rally and achieved FIDO2 Server Certification for passkey-based authentication. These certifications validate Aware's biometric liveness and identity verification technologies against industry-standard benchmarks and sophisticated attack scenarios.Stock TitanAware Q4 and 2025 results webcast March 4, 5 p.m. ETAware, Inc. announced it will hold a webcast on Wednesday, March 4, 2026, at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company stated that financial results will be issued via press release prior to the call, with management hosting a presentation followed by a question-and-answer session. The presentation and audio recording will be made available in the investor relations section of the company's website.GlobeNewswireAware Sets Fourth Quarter and Full Year 2025 Webcast for Wednesday, March 4, 2026, at 5:00 p.m. Eastern TimeAware, Inc. announced it will hold a webcast on Wednesday, March 4, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company stated that financial results will be issued in a press release before the call, and management will host a presentation followed by a question-and-answer session. The audio recording will be available for replay on the company's website for approximately 90 days following the live event.Biometric UpdateDoD expands research on biometric enabled hearing protection systemsThe Department of Defense has received a $7.5 million program increase in the Fiscal Year 2026 defense appropriations bill to accelerate development of next-generation hearing protection integrated with biometric sensing capabilities, working with Aware Defense and the U.S. Army. The funding targets one of the most common service-connected disabilities among veterans—noise-induced hearing loss and tinnitus—by developing custom-fit earpieces built from 3D scans of individual service members' ear canals. Congressional supporters view the investment as potentially reducing long-term VA disability compensation costs while advancing the Pentagon's broader goal of networked, multifunctional soldier equipment.